NICE to discuss Zolgensma at 8th October Committee meeting
14 July 2020
Onasemnogene abeparvovec (Zolgensma) has been rescheduled into the National Institute for Health and Care Excellence’s (NICE’s) work programme and is due to be discussed at committee on this date. Patient and Clinical Experts will take part in the meeting. NICE is expected to publish its recommendation on 25th March 2021. This will state whether it recommends the treatment is funded by the NHS and if so, which children should be included.